Abstract

Focus on engineering biology is at the forefront of the UK government's objectives, being one of their five critical technologies (the others being quantum technologies, artifical intelligence, semiconductors, and future telecommunications), with a recent announcement of £2billion to be invested into the field over the next 10years. With such attention being given to engineering biology within the UK, it is critical to envisage realistic downstream channels (i.e. scale up and route to market) for this investment in order to maximise successful outcomes. This article aims to identify, from the perspective of a UK Bioplastics small and medium-sized enterprise, areas within the scope of engineering biology that should be focused on to maximise potential for success.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.